Skip to main content

Antipodean Advisors LLC

SEC CIK
0001512566
Latest filing
Nov 14, 2023

Holdings in Q3 2022

Holdings as of Sep 30, 2022, filed Nov 14, 2022. Long positions only; changes compare share counts with Q2 2022.

Institution overview
Positions
7
−2 vs. Q2 2022
Portfolio value
$39.1M
−$22.3M (−36.3%) vs. Q2 2022
Filed
Nov 14, 2022
SEC
Holdings of Antipodean Advisors LLC in Q3 2022
SecurityClassSharesValue% of portfolioShare changeActionHistory
SESea LtdSPONSORD ADS350,000$19.6M50.2%00.0%UnchangedHistory
CVNACarvana Co.CL A355,000$7.21M18.4%−50,000−12.3%ReducedHistory
CDLXCardlytics, Inc.COM540,400$5.08M13.0%−98,400−15.4%ReducedHistory
ATRAAtara Biotherapeutics, Inc.COM1,000,000$3.78M9.7%00.0%UnchangedHistory
CMAXCareMax, Inc.COM CL A425,000$3.01M7.7%00.0%UnchangedHistory
VanEck ETF Trust92189F106GOLD MINERS ETF10,000$241.0K0.6%−50,000−83.3%Reduced–
VanEck Vectors ETF Tr92189F403RUSSIA ETF25,000$141.0K0.4%−25,000−50.0%Reduced–

Sold out since Q2 2022 (2)

Positions held at the end of Q2 2022 that are gone from this filing.

Positions of Antipodean Advisors LLC sold out since Q2 2022
SecurityClassShares in Q2 2022Value in Q2 2022% of portfolio in Q2 2022History
iShares Tr464287184CHINA LG-CAP ETF50,000$1.70M2.8%–
Kraneshares Trust500767306CSI CHI INTERNET50,000$1.64M2.7%–